Smad3: An emerging target for vocal fold fibrosis
- 16 April 2014
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 124 (10) , 2327-2331
Abstract
Objectives/Hypothesis: To determine the efficacy of small interfering RNA (siRNA) targeting Smad3 to mediate fibroplasia in vitro, to investigate the temporal regulation of Smad3 following vocal fold (VF) injury, and to determine the local and distal effects of Smad3 siRNA VF injection.Study Design: In vitro and in vivo.Methods: In vitro, Smad3 regulation was examined at both the level of transcription and translation in a human VF cell line in response to Smad3 siRNA ± transforming growth factor β (TGF‐β). Collagen transcription was also examined. In vivo, Smad3 messenger RNA (mRNA) expression was quantified as a function of time following rabbit VF injury. Also, the effects of injected Smad3 siRNA were assessed at local and distal sites.Results: Smad3 siRNA knocked down Smad3 transcription and translation and limited TGF‐β‐mediated collagen mRNA expression with minimal cytotoxicity in vitro. In vivo, Smad3 mRNA increased 1 day following VF injury and remained elevated through day 7. Smad3 siRNA injection into the uninjured vocal fold had no local or distant effect on Smad3 mRNA at multiple organ sites.Conclusions: These data provide a foundation for further investigation regarding the development of novel RNA‐based therapeutics for the VF, specifically locally delivered siRNA for challenging fibrotic conditions of the VF.Level of Evidence: NA Laryngoscope 124:2327–2331, 2014Keywords
This publication has 22 references indexed in Scilit:
- RNA-Based Therapeutics: Current Progress and Future ProspectsChemistry & Biology, 2012
- Efficacy of percutaneous vocal fold injections for benign laryngeal lesions: Prospective multicenter studyActa Oto-Laryngologica, 2011
- Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA‐mediated gene silencingBiotechnology and Bioengineering, 2007
- Office Steroid Injections of the LarynxThe Laryngoscope, 2006
- TGF‐β signaling and the fibrotic responseThe FASEB Journal, 2004
- Smad3 as a mediator of the fibrotic responseInternational Journal of Experimental Pathology, 2004
- The roles of Transforming growth Factor Type ?3(TGF-?3) and mast cells in the pathogenesis of sclerodermaClinical Rheumatology, 2003
- siRNAs knock down hepatitisNature Medicine, 2003
- RNA interference in adult miceNature, 2002
- The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell, 1993